Ideal Power Inc 
IPWR today announced the completion of Phase II deliverables of a product development agreement with Stellantis NV 
STLA.
Ideal Power is partnering with Stellantis’ advanced technology development team to develop a custom B-TRAN power module for use in electric vehicle (“EV”) drivetrain inverters in Stellantis’ next-generation EV platform.
Due to its compelling advantages, B-TRAN is also being evaluated for the automaker’s vehicle power management and EV charging ecosystem.
Also Read: Ideal Power Launches SymCool Power Modules, Eyes Major OEM Partnerships for 2024
All Phase I deliverables were completed, including a wafer run and delivery of packaged and tested B-TRAN devices and test boards to Stellantis and the program’s packaging company. Ideal Power also provided Stellantis with technical support, device characterization, and test data on B-TRAN performance and related drive circuitry.
All Phase II deliverables were completed before schedule, including a wafer run and delivery of tested B-TRAN devices and drivers to the program’s packaging company and the organization building the initial drivetrain inverter. In Phase II, Ideal Power collaborated closely with Stellantis and the program partners to supply B-TRAN devices for integration into the custom power module and inverter designs.
Phase III builds on completing all Phase I and II deliverables and transitions to Stellantis’ production team.
Ideal Power and Stellantis are currently finalizing the scope of work for the next phase of the program.
This phase will likely include the extensive testing of the custom B-TRAN module to meet automotive certification standards, enabling B-TRAN to be the core of the powertrain inverter for the automaker’s next-generation EVs.
This phase’s objective is to complete and certify a production-ready B-TRAN-based module targeted for 2025.
Ideal Power CEO Dan Brdar said, “We are leveraging our success with Stellantis to attract and engage other automobile OEMs and Tier 1 auto suppliers.”
Price Action: IPWR shares are trading higher by 6.18% at $11.16 premarket on the last check Thursday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.